Ramakrishnan Ramesh 4
4 · Talis Biomedical Corp · Filed Aug 17, 2021
Insider Transaction Report
Form 4
Ramakrishnan Ramesh
Sr. Vice President, R&D
Transactions
- Exercise/Conversion
Common Stock
2021-08-13$1.50/sh+8,741$13,112→ 66,121 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-13−8,741→ 0 totalExercise: $1.50Exp: 2021-08-14→ Common Stock (8,471 underlying) - Exercise/Conversion
Common Stock
2021-08-13$1.50/sh+43,614$65,421→ 57,380 total - Sale
Common Stock
2021-08-13$7.66/sh−27,502$210,665→ 38,619 total - Exercise/Conversion
Stock Option (right to buy)
2021-08-13−43,614→ 0 totalExercise: $1.50Exp: 2021-08-14→ Common Stock (43,614 underlying)
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
- [F2]1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.
- [F3]25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.